Heru
Miami
About Heru
Heru Inc. (www.SeeHeru.com) has developed patented autonomous AI-powered vision diagnostics and augmentation software for use on commercially available AR/VR devices. This technology exceeds traditional standards of care in clinical equivalence, usability, cost, size, and portability. Heru is the only cross-platform solution that can autonomously diagnose vision defects and customize individual vision augmentation based on the user’s unique vision defects. Heru originated as a spinout from Bascom Palmer Eye Institute. In December 2020, Heru announced FDA registration and a seed round led by Fred Drasner, Maurice R. Ferre, M.D., Fred H. Moll, M.D., and a consortium of investors with extensive experience developing, launching, and scaling cutting-edge medical technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $32.7M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2021)
- Website: seeheru.com
- Phone: 1-800-601-5061
Industries & Categories
Artificial Intelligence (AI), Augmented Reality, Health Diagnostics, Medical Device, Virtual Reality
Social Profiles
Canonical: https://fsome.com/organization/heru-37757 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.